Hypoaldosteronism epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}}{{Akshun}}
{{CMG}}; {{AE}}{{Akshun}}
==Overview==
==Overview==
In hospitalized patients the incidence rate of hypoaldosteronism is 3000 per 100,000 individuals. The prevalence rate of hypoaldosteronism in United states is estimated to be 200,000 cases. Hypoaldosteronism is most commonly seen in middle-aged and older individuals. Both men and women are affected equally. Hypoaldosteronism is more prevalent in African-American, Native Americans, and Hispanics.
In hospitalized [[patients]] the [[incidence rate]] of hypoaldosteronism is 3000 per 100,000 individuals. The [[prevalence]] rate of hypoaldosteronism in United states is estimated to be 200,000 cases. Hypoaldosteronism is most commonly seen in middle-aged and older individuals. Both men and women are affected equally. Hypoaldosteronism is more prevalent in African-American, Native Americans, and Hispanics.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of hypoaldosteronism in hospitalized patient is approximately 3000 per 100,000 individuals.<ref name="pmid22891694">{{cite journal |vauthors=Haas CS, Pohlenz I, Lindner U, Muck PM, Arand J, Suefke S, Lehnert H |title=Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality? |journal=Clin. Endocrinol. (Oxf) |volume=78 |issue=5 |pages=706–11 |year=2013 |pmid=22891694 |doi=10.1111/j.1365-2265.2012.04446.x |url=}}</ref>
*The [[incidence]] of hypoaldosteronism in hospitalized [[patient]] is approximately 3000 per 100,000 individuals.<ref name="pmid22891694">{{cite journal |vauthors=Haas CS, Pohlenz I, Lindner U, Muck PM, Arand J, Suefke S, Lehnert H |title=Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality? |journal=Clin. Endocrinol. (Oxf) |volume=78 |issue=5 |pages=706–11 |year=2013 |pmid=22891694 |doi=10.1111/j.1365-2265.2012.04446.x |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of hypoaldosteronism is approximately 667 per 100,000 individuals.
*The [[prevalence]] of hypoaldosteronism is approximately 667 per 100,000 individuals.
*The prevalence of hypoaldosteronism is estimated to be 200,000 cases in the United States.
*The [[prevalence]] of hypoaldosteronism is estimated to be 200,000 cases in the United States.


===Age===
===Age===
*Hypoaldosteronism is most commonly seen in middle-aged and older individuals.
*Hypoaldosteronism is most commonly seen in middle-aged and older individuals.
*Elderly patients on multiple drug therapy (polypharmacy) have an increased incidence of drug induced hypoaldosteronism.
*Elderly patients on multiple [[drug]] therapy ([[polypharmacy]]) have an increased [[incidence]] of drug induced hypoaldosteronism.
*In younger patients, hypoaldosteronism is seen in patients with underlying diabetes mellitus type I or sickle cell disease.
*In younger patients, hypoaldosteronism is seen in [[patients]] with underlying [[Diabetes mellitus type 1|diabetes mellitus type I]] or [[sickle cell disease]].


===Race===
===Race===

Revision as of 13:18, 31 August 2017

Hypoaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoaldosteronism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoaldosteronism epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoaldosteronism epidemiology and demographics

CDC on Hypoaldosteronism epidemiology and demographics

Hypoaldosteronism epidemiology and demographics in the news

Blogs on Hypoaldosteronism epidemiology and demographics

Directions to Hospitals Treating Hypoaldosteronism

Risk calculators and risk factors for Hypoaldosteronism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

In hospitalized patients the incidence rate of hypoaldosteronism is 3000 per 100,000 individuals. The prevalence rate of hypoaldosteronism in United states is estimated to be 200,000 cases. Hypoaldosteronism is most commonly seen in middle-aged and older individuals. Both men and women are affected equally. Hypoaldosteronism is more prevalent in African-American, Native Americans, and Hispanics.

Epidemiology and Demographics

Incidence

  • The incidence of hypoaldosteronism in hospitalized patient is approximately 3000 per 100,000 individuals.[1]

Prevalence

  • The prevalence of hypoaldosteronism is approximately 667 per 100,000 individuals.
  • The prevalence of hypoaldosteronism is estimated to be 200,000 cases in the United States.

Age

Race

  • Hypoaldosteronism is more prevalent in African-American, Native Americans, and Hispanics.

Gender

  • Hypoaldosteronism affects both men and women equally.

References

  1. Haas CS, Pohlenz I, Lindner U, Muck PM, Arand J, Suefke S, Lehnert H (2013). "Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality?". Clin. Endocrinol. (Oxf). 78 (5): 706–11. doi:10.1111/j.1365-2265.2012.04446.x. PMID 22891694.

Template:WH Template:WS